We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Incyte Corporation | NASDAQ:INCY | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.67 | 1.26% | 53.76 | 50.05 | 54.50 | 53.87 | 52.73 | 53.70 | 1,407,391 | 01:00:00 |
From May 2019 to May 2024
Incyte Corporation (Nasdaq:INCY) announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 1:30 pm (PST) in San Francisco.
The presentation and Q&A session will be webcast live and can be accessed at www.incyte.com in the Investors section under “Events and Presentations.” Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171214005001/en/
Incyte CorporationMediaCatalina Loveman, +1 302-498-6171cloveman@incyte.comorInvestorsMichael Booth, DPhil, +1 302-498-5914mbooth@incyte.com
1 Year Incyte Chart |
1 Month Incyte Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
